1. Marwick TH, Ritchie R, Shaw JE, Kaye D. Implications of underlying mechanisms for
the recognition and management of diabetic cardiomyopathy. J Am Coll Cardiol.
2018 Jan 23;71(3):339-351.
2. Dunlay SM, Givertz MM, Aguilar D, et al. Type 2 diabetes mellitus and heart failure:
a scientific statement from the American Heart Association and the Heart Failure Society
of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA
heart failure guideline update. Circulation. 2019;140(7):e294-e324.
3. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the
management of heart failure. J Am Coll Cardiol. 2013;62(16):e147-239.
4. Faden G, Faganelo G, De Feo S, et al. The increasing detection of asymptomatic left
ventricular dysfunction in patients with type 2 diabetes mellitus without overt cardiac
disease: data from the SHORTWAVE study. Diabetes Res Clin Pract. 2013;101(3):309-316.
5. Bloom MW, Greenberg B, Jaarsma T, et al. Heart failure with reduced ejection
fraction. Nat Rev Dis Primers. 2017;3:17058.